Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Gaudet

Showing results (211-220 of 304) with videos related to

Pageof 31
Sort By:
Nature Medicine|July 10, 2025
Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trialDaniel Gaudet, Malgorzata Gonciarz, Xi Shen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 21, 2011
Genome-wide scan for loci of adolescent obesity and their relationship with blood pressureMelkaye G Melka, Manon Bernard, Amel Mahboubi, et al.
European Journal of Preventive Cardiology|November 12, 2024
Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemiaAlbert Wiegman, Andrea Ruzza, G Kees Hovingh, et al.
Diabetes|April 28, 2004
Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene regionJose C Florez, Noël Burtt, Paul I W de Bakker, et al.
European Journal of Human Genetics : EJHG|October 22, 2009
Fine mapping and association studies of a high-density lipoprotein cholesterol linkage region on chromosome 16 in French-Canadian subjectsZari Dastani, Päivi Pajukanta, Michel Marcil, et al.
Diabetes|March 1, 2005
Association testing of variants in the hepatocyte nuclear factor 4alpha gene with risk of type 2 diabetes in 7,883 peopleWendy Winckler, Robert R Graham, Paul I W de Bakker, et al.
Journal of the Endocrine Society|November 29, 2019
Differentiating Familial Chylomicronemia Syndrome From Multifactorial Severe Hypertriglyceridemia by Clinical ProfilesLouis St L O'Dea, James MacDougall, Veronica J Alexander, et al.
European Heart Journal|August 30, 2020
Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemiaDaniel Gaudet, Ewa Karwatowska-Prokopczuk, Seth J Baum, et al.
Human Gene Therapy|July 15, 2016
Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced PancreatitisDaniel Gaudet, Erik S Stroes, Julie Méthot, et al.
Atherosclerosis|February 11, 2026
Efficacy of evinacumab by genotype and low-density lipoprotein receptor function in patients with homozygous familial hypercholesterolaemia: A subanalysis from the ELIPSE open-label extension studyFrederick J Raal, Susanne Greber-Platzer, Laurens F Reeskamp, et al.
Pageof 31

Showing results (211-220 of 304) with videos related to

Sort By:
Pageof 31
Nature Medicine|July 10, 2025
Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trialDaniel Gaudet, Malgorzata Gonciarz, Xi Shen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 21, 2011
Genome-wide scan for loci of adolescent obesity and their relationship with blood pressureMelkaye G Melka, Manon Bernard, Amel Mahboubi, et al.
European Journal of Preventive Cardiology|November 12, 2024
Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemiaAlbert Wiegman, Andrea Ruzza, G Kees Hovingh, et al.
Diabetes|April 28, 2004
Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene regionJose C Florez, Noël Burtt, Paul I W de Bakker, et al.
European Journal of Human Genetics : EJHG|October 22, 2009
Fine mapping and association studies of a high-density lipoprotein cholesterol linkage region on chromosome 16 in French-Canadian subjectsZari Dastani, Päivi Pajukanta, Michel Marcil, et al.
Diabetes|March 1, 2005
Association testing of variants in the hepatocyte nuclear factor 4alpha gene with risk of type 2 diabetes in 7,883 peopleWendy Winckler, Robert R Graham, Paul I W de Bakker, et al.
Journal of the Endocrine Society|November 29, 2019
Differentiating Familial Chylomicronemia Syndrome From Multifactorial Severe Hypertriglyceridemia by Clinical ProfilesLouis St L O'Dea, James MacDougall, Veronica J Alexander, et al.
European Heart Journal|August 30, 2020
Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemiaDaniel Gaudet, Ewa Karwatowska-Prokopczuk, Seth J Baum, et al.
Human Gene Therapy|July 15, 2016
Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced PancreatitisDaniel Gaudet, Erik S Stroes, Julie Méthot, et al.
Atherosclerosis|February 11, 2026
Efficacy of evinacumab by genotype and low-density lipoprotein receptor function in patients with homozygous familial hypercholesterolaemia: A subanalysis from the ELIPSE open-label extension studyFrederick J Raal, Susanne Greber-Platzer, Laurens F Reeskamp, et al.
Pageof 31